Emerging research indicates that retatrutide, a innovative medication, may significantly impact the treatment of obesity . Unlike many existing weight management solutions, retatrutide operates as both a GLP-1 receiver and a GIP receiver , affecting multiple factors involved in cravings balance and metabolic optimization. Initial medical research